Literature DB >> 16934222

MafA differentiates rat intestinal cells into insulin-producing cells.

Satoshi Nomura1, Takaaki Nakamura, Tetsuya Hashimoto, Yoshihiko Nishio, Hiroshi Maegawa, Motoi Kudo, Atsunori Kashiwagi.   

Abstract

Recent studies have suggested that basic leucine zipper transcription factor MafA has a crucial role in pancreatic beta-cell-specific insulin gene transcription. Thus, we investigated whether MafA overexpression in the intestine induces insulin production in small-intestinal epithelial cells in vivo. Recombinant adenovirus containing MafA gene (Ad-MafA) was prepared and administered orally to streptozocin-treated diabetic rats. Insulin gene expression was observed in the intestine by RT-PCR analysis, and then insulin protein was detected by immunohistochemical analysis after Ad-MafA administration. Furthermore, MafA overexpression in the intestine increased plasma insulin levels and ameliorated hyperglycemia. These results indicate that MafA overexpression in the intestine induces intestinal epithelial cells newly to produce and release insulin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934222     DOI: 10.1016/j.bbrc.2006.08.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding.

Authors:  Shuangli Guo; Nathan L Vanderford; Roland Stein
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

Review 2.  MafA and MafB activity in pancreatic β cells.

Authors:  Yan Hang; Roland Stein
Journal:  Trends Endocrinol Metab       Date:  2011-06-28       Impact factor: 12.015

3.  Cell replacement and regeneration therapy for diabetes.

Authors:  Hee-Sook Jun
Journal:  Korean Diabetes J       Date:  2010-04-30

4.  Islet-1 Is essential for pancreatic β-cell function.

Authors:  Benjamin N Ediger; Aiping Du; Jingxuan Liu; Chad S Hunter; Erik R Walp; Jonathan Schug; Klaus H Kaestner; Roland Stein; Doris A Stoffers; Catherine L May
Journal:  Diabetes       Date:  2014-07-15       Impact factor: 9.461

5.  Protein therapy using MafA fused to a polyarginine transduction domain attenuates glucose levels of streptozotocin‑induced diabetic mice.

Authors:  Jun Lu; Lingjing Lin; Huiyue Dong; Xin Meng; Fang Fang; Qinghua Wang; Lianghu Huang; Jianming Tan
Journal:  Mol Med Rep       Date:  2017-05-02       Impact factor: 2.952

6.  Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD.

Authors:  So Hyun Lee; Marie Rhee; Ji Won Kim; Kun Ho Yoon
Journal:  Diabetes Metab J       Date:  2017-10       Impact factor: 5.376

Review 7.  Reprogramming Cells to Make Insulin.

Authors:  Wendy M McKimpson; Domenico Accili
Journal:  J Endocr Soc       Date:  2019-04-24

8.  Recombinant adenovirus-mediated intestinal trefoil factor gene therapy for burn-induced intestinal mucosal injury.

Authors:  Yong Sun; Yun Zhu; Liangxi Wang; Xuefei Mao; Xi Peng; Yizhi Peng
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 9.  Engineering the gut for insulin replacement to treat diabetes.

Authors:  Majid Mojibian; Maria M Glavas; Timothy J Kieffer
Journal:  J Diabetes Investig       Date:  2016-03-14       Impact factor: 4.232

10.  Comparison of enteroendocrine cells and pancreatic β-cells using gene expression profiling and insulin gene methylation.

Authors:  Gyeong Ryul Ryu; Esder Lee; Jong Jin Kim; Sung-Dae Moon; Seung-Hyun Ko; Yu-Bae Ahn; Ki-Ho Song
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.